Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study

Jochen G. Mainz, Katja Schaedlich, Claudia Schien, R. Michl, P. Schelhorn-Neise, Assen Koitschev, Christiane Koitschev, J. Riethmueller, Baerbel Wiedemann, James F. Beck, Peter M. KellerDrug 2014 · DOI

Abstract

Sinonasal inhalation of vibrating antibiotic aerosols appears promising for reducing pathogen colonization of paranasal sinuses and for control of symptoms in patients with CF.
BibTeX
@inproceedings{mainz2014sinonasal,
  author = {Jochen G. Mainz and Katja Schaedlich and Claudia Schien and R. Michl and P. Schelhorn-Neise and Assen Koitschev and Christiane Koitschev and J. Riethmueller and Baerbel Wiedemann and James F. Beck and Peter M. Keller},
  title = {{Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study}},
  booktitle = {Drug},
  year = {2014},
  doi = {10.2147/dddt.s54064},
}

Loading related content...

Figure